Home > Insider Trading > Filing (0001104659-24-103002)

Filing Details

Accession Number:: 0001104659-24-103002
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-09-26 08:15:12
Reporting Period:: 2024-09-24

Accepted Time:: 2024-09-26 08:15:12
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1814114	Orchestra Biomed Holdings Inc.	OBIO	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1292834	P David Hochman	C/O Orchestra Biomed Holdings, Inc. 150 Union Square Drive New Hope PA 18938	See Remarks	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.0001 Per Share ("Common Stock")	Acquisiton	2024-09-24	2,500	$4.91	570,498	No	4	P	Direct
Common Stock	Acquisiton	2024-09-25	1,500	$4.86	335,002	No	4	P	Indirect	By the DPH 2008 Trust
Common Stock	Acquisiton	2024-09-25	2,000	$4.74	2,000	No	4	P	Indirect	By the Solomon Ascher Hochman 2019 Trust
Common Stock	Acquisiton	2024-09-25	2,000	$4.70	2,000	No	4	P	Indirect	By the Hannah Hochman 2019 Trust
Common Stock	Acquisiton	2024-09-25	2,000	$4.73	2,000	No	4	P	Indirect	By the Judah Herman Hochman 2019 Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Indirect	By the DPH 2008 Trust
No	4	P	Indirect	By the Solomon Ascher Hochman 2019 Trust
No	4	P	Indirect	By the Hannah Hochman 2019 Trust
No	4	P	Indirect	By the Judah Herman Hochman 2019 Trust

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	3,140	Indirect	By the NSH 2008 Family Trust

Footnotes

The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.90 to $4.95. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.83 to $4.87, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.72 to $4.75. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.68 to $4.77. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.72 to $4.77. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.